Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Multicenter, Prospective, Randomized Controlled Study

NCT06009042 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06009042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06009042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Multicenter, Prospective, Randomized Controlled Study
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 1, 2022
Completion date
June 30, 2024
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hfrs (hemorrhagic fever with renal syndrome)